Myogenesis is the formation of muscular tissue, particularly during embryonic development.
Muscle fibers generally form the fusion of myoblasts into multi-nucleated fibers called myotubes. In the early development of an embryo, myoblasts can either proliferate, or differentiate into a myotube. What controls this choice in vivo is generally unclear. If placed in cell culture, most myoblasts will proliferate if enough fibroblast growth factor (FGF) or another growth factor is present in the medium surrounding the cells. When the growth factor runs out, the myoblasts cease division and undergo terminal differentiation into myotubes. Myoblast differentiation proceeds in stages. The first stage, involves cell cycle exit and the commencement of expression of certain genes.
The second stage of differentiation involves the alignment of the myoblasts with one another. Studies have shown that even rat and chick myoblasts can recognise and align with one another, suggesting evolutionary conservation of the mechanisms involved.[1]
The third stage is the actual cell fusion itself. In this stage, the presence of calcium ions is critical. In mice, fusion is aided by a set of metalloproteinases called meltrins and a variety of other proteins still under investigation. Fusion involves recruitment of actin to the plasma membrane, followed by close apposition and creation of a pore that subsequently rapidly widens.
Novel genes and their protein products that are expressed during the process are under active investigation in many laboratories. They include:
There are a number of stages (listed below) of muscle development, or myogenesis.[4] Each stage has various associated genetic factors lack of which will result in muscular defects.
Associated Genetic Factors: PAX3 and c-MetMutations in PAX3 can cause a failure in c-Met expression. Such a mutation would result in a lack of lateral migration.
PAX3 mediates the transcription of c-Met and is responsible for the activation of MyoD expressionone of the functions of MyoD is to promote the regenerative ability of satellite cells (described below).[4] PAX3 is generally expressed at its highest levels during embryonic development and is expressed at a lesser degree during the fetal stages; it is expressed in migrating hypaxial cells and dermomyotome cells, but is not expressed at all during the development of facial muscle.[4] Mutations in Pax3 can cause a variety of complications including Waardenburg syndrome I and III as well as craniofacial-deafness-hand syndrome.[4] Waardenburg syndrome is most often associated with congenital disorders involving the intestinal tract and spine, an elevation of the scapula, among other symptoms. Each stage has various associated genetic factors without which will result in muscular defects.[4]
Associated Genetic Factors: c-Met/HGF and LBX1Mutations in these genetic factors causes a lack of migration.
LBX1 is responsible for the development and organization of muscles in the dorsal forelimb as well as the movement of dorsal muscles into the limb following delamination.[4] Without LBX1, limb muscles will fail to form properly; studies have shown that hindlimb muscles are severely affected by this deletion while only flexor muscles form in the forelimb muscles as a result of ventral muscle migration.[4]
c-Met is a tyrosine kinase receptor that is required for the survival and proliferation of migrating myoblasts. A lack of c-Met disrupts secondary myogenesis andas in LBX1prevents the formation of limb musculature.[4] It is clear that c-Met plays an important role in delamination and proliferation in addition to migration. PAX3 is needed for the transcription of c-Met.[4]
Associated Genetic Factors: PAX3, c-Met, Mox2, MSX1, Six, Myf5, and MyoD
Mox2 (also referred to as MEOX-2) plays an important role in the induction of mesoderm and regional specification.[4] Impairing the function of Mox2 will prevent the proliferation of myogenic precursors and will cause abnormal patterning of limb muscles.[5] Specifically, studies have shown that hindlimbs are severely reduced in size while specific forelimb muscles will fail to form.[4]
Myf5 is required for proper myoblast proliferation.[4] Studies have shown that mice muscle development in the intercostal and paraspinal regions can be delayed by inactivating Myf-5.[4] Myf5 is considered to be the earliest expressed regulatory factor gene in myogenesis. If Myf-5 and MyoD are both inactivated, there will be a complete absence of skeletal muscle.[4] These consequences further reveal the complexity of myogenesis and the importance of each genetic factor in proper muscle development.
Associated Genetic Factors: Myf5 and MyoDOne of the most important stages in myogenesis determination requires both Myf5 and MyoD to function properly in order for myogenic cells to progress normally. Mutations in either associated genetic factor will cause the cells to adopt non-muscular phenotypes.[4]
As stated earlier, the combination of Myf5 and MyoD is crucial to the success of myogenesis. Both MyoD and Myf5 are members of the myogenic bHLH (basic helix-loop-helix) proteins transcription factor family.[6] Cells that make myogenic bHLH transcription factors (including MyoD or Myf5) are committed to development as a muscle cell.[7] Consequently, the simultaneous deletion of Myf5 and MyoD also results in a complete lack of skeletal muscle formation.[7] Research has shown that MyoD directly activates its own gene; this means that the protein made binds the myoD gene and continues a cycle of MyoD protein production.[7] Meanwhile, Myf5 expression is regulated by Sonic hedgehog, Wnt1, and MyoD itself.[4] By noting the role of MyoD in regulating Myf5, the crucial interconnectedness of the two genetic factors becomes clear.[4]
Associated Genetic Factors: Myogenin, Mcf2, Six, MyoD, and Myf6Mutations in these associated genetic factors will prevent myocytes from advancing and maturing.
Myogenin (also known as Myf4) is required for the fusion of myogenic precursor cells to either new or previously existing fibers.[4] In general, myogenin is associated with amplifying expression of genes that are already being expressed in the organism. Deleting myogenin results in nearly complete loss of differentiated muscle fibers and severe loss of skeletal muscle mass in the lateral/ventral body wall.[4]
Myf-6 (also known as MRF4 or Herculin) is important to myotube differentiation and is specific to skeletal muscle.[4] Mutations in Myf-6 can provoke disorders including centronuclear myopathy and Becker muscular dystrophy.[4]
Associated Genetic Factors: LBX1 and Mox2In specific muscle formation, mutations in associated genetic factors begin to affect specific muscular regions. Because of its large responsibility in the movement of dorsal muscles into the limb following delamination, mutation or deletion of Lbx1 results in defects in extensor and hindlimb muscles.[4] As stated in the Proliferation section, Mox2 deletion or mutation causes abnormal patterning of limb muscles. The consequences of this abnormal patterning include severe reduction in size of hindlimbs and complete absence of forelimb muscles.[4]
Associated Genetic Factors: PAX7Mutations in Pax7 will prevent the formation of satellite cells and, in turn, prevent postnatal muscle growth.[4]
Satellite cells are described as quiescent myoblasts and neighbor muscle fiber sarcolemma.[4] They are crucial for the repair of muscle, but have a very limited ability to replicate. Activated by stimuli such as injury or high mechanical load, satellite cells are required for muscle regeneration in adult organisms.[4] In addition, satellite cells have the capability to also differentiate into bone or fat. In this way, satellite cells have an important role in not only muscle development, but in the maintenance of muscle through adulthood.[4]
During embryogenesis, the dermomyotome and/or myotome in the somites contain the myogenic progenitor cells that will evolve into the prospective skeletal muscle.[8] The determination of dermomyotome and myotome is regulated by a gene regulatory network that includes a member of the T-box family, tbx6, ripply1, and mesp-ba.[9] Skeletal myogenesis depends on the strict regulation of various gene subsets in order to differentiate the myogenic progenitors into myofibers. Basic helix-loop-helix (bHLH) transcription factors, MyoD, Myf5, myogenin, and MRF4 are critical to its formation. MyoD and Myf5 enable the differentiation of myogenic progenitors into myoblasts, followed by myogenin, which differentiates the myoblast into myotubes.[8] MRF4 is important for blocking the transcription of muscle-specific promoters, enabling skeletal muscle progenitors to grow and proliferate before differentiating.
There are a number of events that occur in order to propel the specification of muscle cells in the somite. For both the lateral and medial regions of the somite, paracrine factors induce myotome cells to produce MyoD proteinthereby causing them to develop as muscle cells.[10] A transcription factor (TCF4) of connective tissue fibroblasts is involved in the regulation of myogenesis. Specifically, it regulates the type of muscle fiber developed and its maturations.[4] Low levels of TCF4 promote both slow and fast myogenesis, overall promoting the maturation of muscle fiber type. Thereby this shows the close relationship of muscle with connective tissue during the embryonic development.[11]
Regulation of myogenic differentiation is controlled by two pathways: the phosphatidylinositol 3-kinase/Akt pathway and the Notch/Hes pathway, which work in a collaborative manner to suppress MyoD transcription.[6] The O subfamily of the forkhead proteins (FOXO) play a critical role in regulation of myogenic differentiation as they stabilize Notch/Hes binding. Research has shown that knockout of FOXO1 in mice increases MyoD expression, altering the distribution of fast-twitch and slow-twitch fibers.[6]
Primary muscle fibers form from primary myoblasts and tend to develop into slow muscle fibers.[4] Secondary muscle fibers then form around the primary fibers near the time of innervation. These muscle fibers form from secondary myoblasts and usually develop as fast muscle fibers. Finally, the muscle fibers that form later arise from satellite cells.[4]
Two genes significant in muscle fusion are Mef2 and the twist transcription factor. Studies have shown knockouts for Mef2C in mice lead to muscle defects in cardiac and smooth muscle development, particularly in fusion.[12] The twist gene plays a role in muscle differentiation.
The SIX1 gene plays a critical role in hypaxial muscle differentiation in myogenesis. In mice lacking this gene, severe muscle hypoplasia affected most of the body muscles, specifically hypaxial muscles.[13]
There are 3 types of proteins produced during myogenesis.[5] Class A proteins are the most abundant and are synthesized continuously throughout myogenesis. Class B proteins are proteins that are initiated during myogenesis and continued throughout development. Class C proteins are those synthesized at specific times during development. Also 3 different forms of actin were identified during myogenesis.
Sim2, a BHLH-Pas transcription factor, inhibits transcription by active repression and displays enhanced expression in ventral limb muscle masses during chick and mouse embryonic development. It accomplishes this by repressing MyoD transcription by binding to the enhancer region, and prevents premature myogenesis.[14]
Delta1 expression in neural crest cells is necessary for muscle differentiation of the somites, through the Notch signaling pathway. Gain and loss of this ligand in neural crest cells results in delayed or premature myogenesis.[15]
The significance of alternative splicing was elucidated using microarrary analysis of differentiating C2C12 myoblasts.[16] 95 alternative splicing events occur during C2C12 differentiation in myogenesis. Therefore, alternative splicing is necessary in myogenesis.
Systems approach is a method used to study myogenesis, which manipulates a number of different techniques like high-throughput screening technologies, genome wide cell-based assays, and bioinformatics, to identify different factors of a system.[8] This has been specifically used in the investigation of skeletal muscle development and the identification of its regulatory network.
Systems approach using high-throughput sequencing and ChIP-chip analysis has been essential in elucidating the targets of myogenic regulatory factors like MyoD and myogenin, their inter-related targets, and how MyoD acts to alter the epigenome in myoblasts and myotubes.[8] This has also revealed the significance of PAX3 in myogenesis, and that it ensures the survival of myogenic progenitors.[8]
This approach, using cell based high-throughput transfection assay and whole-mount in situ hybridization, was used in identifying the myogenetic regulator RP58, and the tendon differentiation gene, Mohawk homeobox.[8]
See more here:
- Cardiac Regeneration - Center for Regenerative Medicine - Mayo Clinic ... [Last Updated On: April 11th, 2018] [Originally Added On: April 11th, 2018]
- Cardiac Regeneration - Mayo Clinic [Last Updated On: April 22nd, 2018] [Originally Added On: April 22nd, 2018]
- Materials - MDPI [Last Updated On: May 18th, 2018] [Originally Added On: May 18th, 2018]
- Cardiac Stem Cell Research - Cedars-Sinai [Last Updated On: May 22nd, 2018] [Originally Added On: May 22nd, 2018]
- Cardiac regeneration: current therapiesfuture concepts ... [Last Updated On: May 26th, 2018] [Originally Added On: May 26th, 2018]
- Cardiac Regeneration - Victor Chang Cardiac Research Institute [Last Updated On: May 30th, 2018] [Originally Added On: May 30th, 2018]
- Cardiology Conferences | Cardio 2018 Events | Cardiac ... [Last Updated On: June 6th, 2018] [Originally Added On: June 6th, 2018]
- Laboratory for Cardiac Regeneration | Baylor College of ... [Last Updated On: June 18th, 2018] [Originally Added On: June 18th, 2018]
- Regeneration of Muscle [Last Updated On: July 8th, 2018] [Originally Added On: July 8th, 2018]
- Regeneration of Muscle - eLS: Essential for Life Science [Last Updated On: July 14th, 2018] [Originally Added On: July 14th, 2018]
- Cardiac Repair and Regeneration Research Unit | Heart and ... [Last Updated On: July 25th, 2018] [Originally Added On: July 25th, 2018]
- Regeneration (biology) - Wikipedia [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- World Cardiology and Cardiologist Meeting [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- Cardiac (comics) - Wikipedia [Last Updated On: August 26th, 2018] [Originally Added On: August 26th, 2018]
- Cardiac regeneration and repair - 1st Edition - Elsevier [Last Updated On: September 21st, 2018] [Originally Added On: September 21st, 2018]
- Post-doc position available cardiac regeneration ... [Last Updated On: September 29th, 2018] [Originally Added On: September 29th, 2018]
- UW Bioengineering: Building World Leadership in Heart ... [Last Updated On: September 29th, 2018] [Originally Added On: September 29th, 2018]
- Cardiac Regeneration - What Science Can Do - AstraZeneca [Last Updated On: October 2nd, 2018] [Originally Added On: October 2nd, 2018]
- Cardiac Regeneration, Stem Cells | Research | Baylor ... [Last Updated On: November 30th, 2018] [Originally Added On: November 30th, 2018]
- Cardiac Regeneration - Victor Chang Institute [Last Updated On: December 6th, 2018] [Originally Added On: December 6th, 2018]
- Entering a new era in vascular and cardiac regeneration ... [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Cardiac regeneration and repair - 1st Edition [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Heart Regeneration Technologies [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Cardiac Regeneration - Center for Regenerative Medicine ... [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Zebrafish Heart Regeneration | HHMI BioInteractive [Last Updated On: December 22nd, 2018] [Originally Added On: December 22nd, 2018]
- Rapid cell regeneration - Heroes Wiki [Last Updated On: December 22nd, 2018] [Originally Added On: December 22nd, 2018]
- Cardiac muscle - Wikipedia [Last Updated On: December 23rd, 2018] [Originally Added On: December 23rd, 2018]
- Cardiac regeneration in and : discrepancies and problems ... [Last Updated On: January 8th, 2019] [Originally Added On: January 8th, 2019]
- OHSU Center for Regenerative Medicine Heart Regeneration ... [Last Updated On: January 8th, 2019] [Originally Added On: January 8th, 2019]
- Dr. Sanjiv Dhingra, Cardiac Regeneration and Tissue ... [Last Updated On: January 30th, 2019] [Originally Added On: January 30th, 2019]
- Mending a Broken Heart: Stem Cells and Cardiac Repair ... [Last Updated On: February 20th, 2019] [Originally Added On: February 20th, 2019]
- Cardiac Repair and Regeneration | Division of Cardiology ... [Last Updated On: February 20th, 2019] [Originally Added On: February 20th, 2019]
- Stem Cell Therapy and Stem Cell Injection Provider Finder ... [Last Updated On: March 5th, 2019] [Originally Added On: March 5th, 2019]
- KearnsSayre syndrome - Wikipedia [Last Updated On: March 8th, 2019] [Originally Added On: March 8th, 2019]
- Ruohola-Baker Lab [Last Updated On: March 15th, 2019] [Originally Added On: March 15th, 2019]
- MTS Science [Last Updated On: May 3rd, 2019] [Originally Added On: May 3rd, 2019]
- New Insights Into the Healing Capacity of the Heart: The Hippo Pathway - Cath Lab Digest [Last Updated On: September 26th, 2019] [Originally Added On: September 26th, 2019]
- Conjugated polymers optically regulate the fate of endothelial colony-forming cells - Science Advances [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- The nanoengineer working to mend broken hearts - UNSW Newsroom [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- New insights into heart's healing capacity - Baylor College of Medicine News [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- Tenaya Therapeutics Closes $92 Million Series B Financing - BioSpace [Last Updated On: October 5th, 2019] [Originally Added On: October 5th, 2019]
- Regenerative medicine today: Are diabetes and vascular disease treatments ready for the clinic? - Science Magazine [Last Updated On: October 5th, 2019] [Originally Added On: October 5th, 2019]
- Reviewing resTORbio Inc. (TORC)'s and Anika Therapeutics Inc. (NASDAQ:ANIK)'s results - MS Wkly [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- TAMassociati: the new Church of the Resurrection in Varignano - Floornature.com [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- What the Hippo pathway in cardiac fibroblasts reveals about heart function - Baylor College of Medicine News [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- Capricor Therapeutics to Host Key Opinion Leader Call on the Role of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy (DMD) - BioSpace [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Regenerative Medicine Market Industry Outlook, Growth Prospects and Key Opportunities - Health News Office [Last Updated On: October 24th, 2019] [Originally Added On: October 24th, 2019]
- Ottawa-based treatment a leap forward in addressing heart failure - Winnipeg Sun [Last Updated On: October 27th, 2019] [Originally Added On: October 27th, 2019]
- Global Regenerative Medicines Market Demand Analysis & Opportunity Evaluation Report 2019-2027 with Focus on U.S. & Europe -... [Last Updated On: November 15th, 2019] [Originally Added On: November 15th, 2019]
- The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure - Physician's Weekly [Last Updated On: November 15th, 2019] [Originally Added On: November 15th, 2019]
- SANUWAVE Health Reports Third Quarter 2019 Financial Results Other OTC:SNWV - GlobeNewswire [Last Updated On: November 16th, 2019] [Originally Added On: November 16th, 2019]
- Moderna: Undervalued As The Promising Pipeline Awaits Collaborations - Seeking Alpha [Last Updated On: November 23rd, 2019] [Originally Added On: November 23rd, 2019]
- Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells Derived from Adipose Tissue and Bone Marrow on Acute Myocardial Infarction... [Last Updated On: November 23rd, 2019] [Originally Added On: November 23rd, 2019]
- Stem Cell Therapy May Improve Heart Health In New Ways - TheHealthMania [Last Updated On: December 5th, 2019] [Originally Added On: December 5th, 2019]
- AgeX Therapeutics Issues Year-End Letter to Shareholders - BioSpace [Last Updated On: December 9th, 2019] [Originally Added On: December 9th, 2019]
- Polymeric Biomaterials Market Trends Analysis Forecast to 2019-2024 |Evolving Industry Overview by Types, Applications, Size & Share - Sino News... [Last Updated On: December 16th, 2019] [Originally Added On: December 16th, 2019]
- SMD - Researchers look behind the biological curtain on how fish oil might fight inflammatory disease - QMUL [Last Updated On: December 16th, 2019] [Originally Added On: December 16th, 2019]
- Suspended animation, you say? The biggest and freakiest scientific breakthroughs of 2019 - SYFY WIRE [Last Updated On: December 29th, 2019] [Originally Added On: December 29th, 2019]
- 2019: Year in Pictures by Robert Cohen | Metro - STLtoday.com [Last Updated On: December 31st, 2019] [Originally Added On: December 31st, 2019]
- MicroCures Announces Issuance of New Patent Covering First-of-its-Kind Cell Movement Decelerator Technology with Potential Applications in Oncology... [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- Cells that regenerate heart in zebrafish discovered - Biology Reporter [Last Updated On: February 7th, 2020] [Originally Added On: February 7th, 2020]
- SANUWAVE Health Appoints Dr. Tom Price to Its Board of Directors - Yahoo Finance [Last Updated On: February 7th, 2020] [Originally Added On: February 7th, 2020]
- Capricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update - Associated Press [Last Updated On: March 19th, 2020] [Originally Added On: March 19th, 2020]
- Researchers and Doctors alike pursuing the field of stem cell research in treating heart attack survivors - Medical Herald [Last Updated On: March 19th, 2020] [Originally Added On: March 19th, 2020]
- Artificial Heart Lung Machines Market report reviews opportunities and analysis by size, share, trends, manufacturer, forecast 2020-2026 - WhaTech... [Last Updated On: April 29th, 2020] [Originally Added On: April 29th, 2020]
- Scientists have figured out how to make the heart to regenerate - The Times Hub [Last Updated On: April 29th, 2020] [Originally Added On: April 29th, 2020]
- Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat dietinduced obesity - Science Advances [Last Updated On: May 9th, 2020] [Originally Added On: May 9th, 2020]
- SANUWAVE HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com [Last Updated On: May 15th, 2020] [Originally Added On: May 15th, 2020]
- SANUWAVE Health to Hold First Quarter Financial Results and Business Update Call on Monday, May 18, 2020 - Yahoo Finance [Last Updated On: May 15th, 2020] [Originally Added On: May 15th, 2020]
- SANUWAVE Health to Hold Investor Live Webcast on Wednesday, June 10, 2020 - Yahoo Finance [Last Updated On: June 10th, 2020] [Originally Added On: June 10th, 2020]
- SANUWAVE Health Enters Into Exclusive Letter of Intent to Acquire Celularity's UltraMIST and Exclusive Partnership Rights for Wound Care Biologic... [Last Updated On: June 11th, 2020] [Originally Added On: June 11th, 2020]
- SANUWAVE Health, Inc. Discusses The Potential of Their Celularity Acquisition with The Stock Day Podcast (SNWV) July 1, 2020 - Stock Day Media [Last Updated On: July 1st, 2020] [Originally Added On: July 1st, 2020]
- Interim Analysis of Recardio's Phase II Clinical Trial to Be Presented at the 2020 Congress of the European Society of Cardiology - PRNewswire [Last Updated On: July 1st, 2020] [Originally Added On: July 1st, 2020]
- Growth and demand of Plasma Therapy in the Asia Pacific Region available in the latest report - WhaTech Technology and Markets News [Last Updated On: July 4th, 2020] [Originally Added On: July 4th, 2020]
- Plasma Therapy Market Size by Top Companies, Regions, Types and Application, End Users and Forecast to 2027 - Bulletin Line [Last Updated On: August 14th, 2020] [Originally Added On: August 14th, 2020]
- Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen for Vascular Repair - BioSpace [Last Updated On: August 14th, 2020] [Originally Added On: August 14th, 2020]
- Polymeric Biomaterials Market Insights by Current Trends 2020 Future Demand by Top Key Players, Regions, Industry Size, and Business Strategy... [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]
- CORRECTION - SANUWAVE Health Announces Reimbursement Coverage for BIOVANCE From Largest Medicare and Medicaid Administrator in U.S. - Stockhouse [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]
- New Research Paper Suggests RegeneRx's Thymosin Beta 4 May be Useful in Treating COVID-19 - PRNewswire [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]
- To Repair a Damaged Heart, Three Cells are Better Than One - SDSU Newscenter [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]